This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Society news


2016 Grahame-Smith Prize winner

25 Oct 2016

Dr James Dear, University of Edinburgh, is the 2016 winner of the Grahame-Smith Prize

The Society's response to 'The Changing UK Drug Discovery Landscape'

20 Oct 2016

Professor David Webb, President of the British Pharmacological Society, responds to a new report from the Association of the British Pharmaceutical Industry on The Changing UK Drug Discovery Landscape.

BJCP article: Genetic variants may affect breast cancer drug concentrations and patient outcomes

17 Oct 2016

In a study of 110 women taking the breast cancer drug anastrozole, there were significant differences in patients’ blood levels of the drug that corresponded with variations in the ABCB1 gene.

BJP article: Starving pancreatic cancer cells - Scientists identify potential pancreatic cancer target

17 Oct 2016

Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic cells.

Maintaining a healthy body – Advice from an Olympic champion

12 Oct 2016

Experts in how drugs work from the British Pharmacological Society have teamed up with Olympic Gold Medallist Tim Foster on a new animation about maintaining a healthy body without the use of illicit drugs. The 3-minute animation was launched on YouTube and social media today to help 10–14 year olds make safer decisions about performance and image enhancing drugs.

BJP article: Are natural alternatives to oestrogen replacement therapy safe?

10 Oct 2016

Although individuals often consume natural products because of their potential health benefits, a new review indicates that it is not clear whether the benefits of plant-derived compounds that mimic oestrogen outweigh the possible health risks. The findings are published in the British Journal of Pharmacology.

Potential impact of immigration reforms is a vital issue for science

07 Oct 2016

The British Pharmacological Society, along with other Societies, has worked with the Royal Society of Biology to develop a response to a series of measures to reduce net immigration proposed by Home Secretary Rt Hon Amber Rudd MP in her speech to the Conservative Party conference.

BJCP article: Making medications safer for newborns

04 Oct 2016

A new editorial in the British Journal of Clinical Pharmacology looks at the challenges of performing clinical trials in newborns, from the reluctance of parents to enroll their infants to the lack of experience of paediatricians and neonatologists in conducting clinical research.

BJP article: Certain alternative therapies may help patients with bowel disorders

04 Oct 2016

A new review in the British Journal of Pharmacology looks at the evidence behind the effectiveness of complementary or alternative therapies—including probiotics, prebiotics, synbiotics, fiber, and herbal medicinal products—for the treatment of bowel disorders such as irritable bowel syndrome (IBS), functional constipation, and ulcerative colitis.

LeSPAR welcomes international action to tackle antimicrobial resistance

27 Sep 2016

The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) welcomes news of global political and pharmaceutical industry support for actions to tackle the threat of resistant infections.   The G7 and G20 summits and the UN General Assembly have now agreed proactive steps to ensure collaboration between nations, accepting the recommendations of the WHO Global Action Plan on AMR and the UK AMR Review.

BJCP article: Study reveals scope and characteristics of adverse drug reactions in the general population

20 Sep 2016

In a study of 1,000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.